Actively Recruiting
Study of the CGM MEPC-2401 Device for Improving Blood Circulation in Adults Aged 19 to 65
Led by Ceragem Clinical Inc. · Updated on 2026-03-03
40
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What this Trial Is About
This research aims to evaluate the safety and effectiveness of a static electricity generator device called the Ceragem Celtron Circulation Chair CGM MEPC-2401 for improving blood circulation in healthy adults aged 19 to 65 years. The study is an open-label, exploratory clinical trial conducted at a single center to assess how this personal electro-potential generator affects blood flow and related parameters. Participants will use the investigational device, the Ceragem Celltron Circulation Chair, for a 30-minute session during which the device applies electric stimulation aimed at enhancing blood circulation. The trial focuses on measuring changes immediately after the application of the device, without any placebo comparison or blinding. During the study, researchers will measure blood flow changes in the dorsal metacarpal vein, capillary diameter, oxygen saturation, and various blood biomarkers before and immediately after the 30-minute device application. Participants will undergo hematology testing and other evaluations to monitor safety and efficacy. The trial will include healthy volunteers with specific body mass index limits and will last through the treatment and immediate assessment period.
CONDITIONS
Brief Title
Electric Stimulation Home Use(CGM MEPC_2401) for Improving Blood Circulation
Research Team
M
Myeongbae Shin, Researcher
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
